Benitec Biopharma, Inc. is a development-stage biotechnology company which focuses on the advancement of novel genetic medicines. The company is headquartered in Hayward, CA.
Company profile
Ticker
BNTCW, BNTCW
Exchange
Website
CEO
Jerel A. Banks
Employees
Location
Industry (SIC)
SEC CIK
Corporate docs
BNTCW stock data
Latest filings (excl ownership)
15-12B
Securities registration termination
27 Apr 20
EFFECT
Notice of effectiveness
17 Apr 20
EFFECT
Notice of effectiveness
17 Apr 20
S-8 POS
Registration of securities for employees (post-effective amendment)
15 Apr 20
POS AM
Prospectus update (post-effective amendment)
15 Apr 20
POS AM
Prospectus update (post-effective amendment)
15 Apr 20
6-K
Benitec Biopharma Appoints Edward Smith to the Board of Directors
15 Apr 20
25
Voluntary exchange delisting
14 Apr 20
25-NSE
Exchange delisting
14 Apr 20
6-K
Current report (foreign)
3 Apr 20
Latest ownership filings
SC 13G/A
Benitec Biopharma LTD/ADR
23 Jan 20
SC 13G/A
Benitec Biopharma LTD/ADR
13 Jan 20
SC 13G
Benitec Biopharma LTD/ADR
8 Oct 19
SC 13G
Benitec Biopharma LTD/ADR
7 Oct 19
SC 13G/A
Benitec Biopharma LTD/ADR
14 Feb 19
SC 13G
Benitec Biopharma LTD/ADR
9 May 18
SC 13D/A
Benitec Biopharma LTD/ADR
15 Mar 17
SC 13D/A
Benitec Biopharma LTD/ADR
3 Mar 17
SC 13G/A
Benitec Biopharma LTD/ADR
9 Jan 17
SC 13D
Benitec Biopharma LTD/ADR
1 Nov 16
Institutional ownership, Q1 2020
| 13F holders | Current |
|---|---|
| Total holders | 0 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 0.00 |
| Total shares | 0.00 |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|